Introduction
Tobacco use is the main preventable cause of morbimortality in the world (Organización Mundiae la Salud, 2021). The prevalence of cigarette use in Spain is above the European mean (22.2% vs. 18.4%), and has remained stable in recent years (EUROSTAT, 2019). In view of the negative effects of tobacco addiction on physical and mental health (Martín-Ríos et al., 2021; Sánchez-Villegas et al., 2021), research focusen progress and improvement of its treatment is crucial to public health. Nevertheless, anespite such progress, long-term abstinence rates are still moderate (~ 20-30%) and relapse rates are high (Stead et al., 2017).
One of the limitations of the existent treatments for smoking cessation is the lack of individualized approaches tailored to the particular characteristics of the smoker, including their mental health status (Leventhal & Zvolensky, 2015; Martínez-Vispo et al., 2020). Multiple studies have shown the relationship between tobacco use and the presence of psychological problems (Zvolensky et al., 2017), of which anxiety anepression are the most closely related to tobacco abstinence and relapse (Pérez-Pareja et al., 2010; Piper et al., 2011). In particular, depressive and anxious symptomatology have been related to greater levels of nicotine dependence (Zvolensky, Farris, et al., 2014), more perceivearriers to smoking cessation (Leventhal & Zvolensky, 2015), lower treatment adherence (Pérez-Pareja et al., 2020), and higher long-term tobacco relapse rates (Zvolensky, Farris, et al., 2014).
Studies analyzing individual factors affecting the onset and maintenance of substance use (see e.g., Ontaneda-Aguilar et al., 2021), including tobacco, as well as long-term relapse, agree on the importance of including techniques specific to such characteristics in standard treatments (González-Roz et al., 2019). In recent years, a transdiagnostic evaluation and treatment model has been implemented for analyzing psychopathological factors common tifferent diagnostic categories (Leventhal & Zvolensky, 2015). One of the transdiagnostic variables most widely studied with regards to tobacco use and which could have a significant impact in tobacco cessation is anxiety sensitivity (AS) (López-Núñez et al., 2021; Zvolensky et al., 2019).
AS is the concept sustaining the Reiss anxiety expectancy model (Reiss, 1991). It is defined as the fear of interoceptive sensations or symptoms indicative of anxiety basen the perception that such sensations have negative somatic, social, or psychological consequences for the person who experiences them. The AS concept is basen classic conditioning and has been proposed as a significant factor predisposing tevelopment of several mental health problems (Rodríguez et al., 2012). Regarding its impact on smoking and smoking cessation, previous studies have shown that smokers with high levels of AS have higher nicotine dependence rates (Zvolensky, Farris, et al., 2014), additionaarriers to quitting smoking given their lower tolerance to abstinence symptoms (Farris et al., 2014; Leventhal & Zvolensky, 2015; Zvolensky, Farris, et al., 2014; Zvolensky et al., 2019), higher treatment dropout rates (Langdon et al., 2016), and higher probability of not achieving smoking abstinence or relapse after successful attempts (Guillot et al., 2016; Martínez-Vispo et al., 2021). Moreover, AS in combination with brooding rumination predicts higher levels of anxiety anepression in treatment-seeking smokers, hindering their quitting success (Martínez-Vispo et al., 2022). Consequently, combined approaches addressing both smoking cessation and AS not only enable transdiagnostic levels of AS te reduced, but also increase long-term abstinence rates (Farris et al., 2015; Schimdt et al., 2016; Zvolensky, Bogiaizian, et al., 2014).
In this context, it shoule mentioned that most of the studies on AS and smoking addiction, whether in the general population or in clinical subsamples, have been carrieut in the United States and Argentina, and very few with Spanish population. In view of the above, the main objectives of this study were: 1) to examine sex differences in variables related to smoking and AS and 2) to examine the mediating effect of AS in a population of adult smokers.
Method
Participants
The inclusion criteria for participants were: 1) being 18 to 65 years of age, 2) having smoked at least 100 cigarettes in their life, and 3) smoking daily. We excluded participants who: 1) did not give their informed consent for participation in the study, 2) had smoked cannabis in the previous week, and 3) had filleut the survey at random or left it incomplete. Recruitment was carrieut through snowball sampling anissemination of the survey on social networks. A totaf 340 participants (see Figure 1) were included in the study (Mage = 33.59, SD = 11.98, 68.5% women). Their sociodemographic characteristics are shown in Table 1.
Note. 1Includes pipe, cigars, mini-cigars, e-cigarettes, and hookah.
Measures
Data were collected through an online survey to evaluate smoking addiction in an adult Spanish population. The survey included information on sociodemographic data (i.e., age, sex, nationality, education, marital status, anccupation) and variables related to smoking behavior (i.e., cigarettes per day, age of tobaccnset, previous quitting attempts, longest periof abstinence, and main reason for the last relapse). Participants also completed the Fagerström Test for Nicotine Dependence (FTND; Heatherton et al., 1991), where five levels of dependence were set by their total score: very low (0-2), low (3-4), moderate (5), high (6-7), or very high (8-10). Lastly, AS was evaluated using the Spanish adaptation (Sandín et al., 2007) of the Anxiety Sensitivity Index-3 (ASI-3). The test consists of 18 items answeren a 5-point Likert-type scale (0 = none or almost none, 4 = very much). The ASI-3 questionnaire has three anxiety sensitivity subscales (physical, cognitive, and social) with six items each (Taylor et al., 2007). Completing all questionnaires took 15-20 minutes.
Procedure
This was a simple correlational, cross-sectional study. The survey was applied in an online format with the Qualtrics platform. The online notebook that included the evaluation instruments was accompaniey an information sheet and the corresponding informed consent, where the objective of the study and confidentiality of data were specified. This study was approvey the Ethics Committee of Universidaoyola Andalucía (20-01-2020) and complies with the principles expressed in the Helsinki Declaration.
Data Analysis
Descriptive analyses were performed to analyze the main variables of interest. Smoking variables and AS were also analyzey participant sex with a Student’s t test for independent samples. The effect size was calculated using the Cohen’s d, with values lower than 0.40 being considered a small effect, values between 0.40 and 0.70 an intermediate effect, and values over 0.70 a large effect. The relationship between smoking variables (i.e., number of cigarettes per day, years smoking, attempts at quitting, and nicotine dependence) and the AS subscales (physical, cognitive, and social) was analyzed with bivariate correlations using the Pearson’s correlation coefficient (r).
A structural equations modelling was carrieut to examine the mediating effect of AS on the relationship between smoking variables (number of cigarettes per day and nicotine dependence) and previous quit attempts. The model fit parameters were estimated using the maximum likelihood estimation method. Three indices were used to evaluate model fit: 1) Tucker-Lewis index (TLI), where values over .90 indicate adequate model fit; 2) Comparative fit index (CFI), where values over .90 suggest good model fit; and 3) root mean square error of approximation (RMSEA), where values below .08 suggest good model fit (Byrne, 2009; Schermelleh-Engel et al., 2003). The confidence level was 95%, anoth IBM SPSS (version 26.0; SPSS, Inc., Chicago, IL) and AMOS (version 23) were used for the analyses.
Results
Characteristics Related to Tobacco and Anxiety Sensitivity
Participants smoked an average of 11.03 cigarettes per day (SD = 4.15), haeen smoking for an average 15.18 years (SD = 10.84), haow nicotine dependence (M = 3.50, SD= 2.46), and had tried to quit smoking a mean of 2.14 times (SD = 2.63). The only significant sex difference was found in the number of cigarettes per day, with men smoking more than women (12.43 ± 8.86 vs. 10.37 ± 7.17, p = .041).
The mean score of participants on the total AS scale was 35.51 (SD = 11.89), and the mean scores on the three AS subscales were 12.61 (SD = 5.33) in physical AS, 9.69 (SD = 4.15) in cognitive AS, and 13.21 (SD = 4.87) in social AS. Results on sex differences showed that women scored higher on the AS scales than men (see Table 2).
Note. ASI-3 = Anxiety Sensitivity Index-3; M = mean; SD = standareviation; d = Cohen’s d.
Anxiety Sensitivity as a Mediator Variable
The structural equation model yielded adequate fit tata, evidencey the fit indices, χ2(6) = 2.65, p = .851; TLI = 1.02; CFI = 1; RMSEA = .005. AS was directly related to the number of previous failed quit attempts (β = .064). There were no significant differences in the structural equation modeasen sex. The structural equation model is shown in Figure 2.
Note. AS = anxiety sensitivity.
Discussion
The main objective of this study was to examine sex differences in tobacco use variables and AS, and to evaluate the mediating effect of AS in a sample of adult smokers. The main results showed that men smoke more cigarettes per day, whereas women score higher in AS. Furthermore, AS is a significant mediator between variables related to tobacco use (i.e., number of cigarettes per day and nicotine dependence) and number of previous quit attempts.
In line with previous research (Chinwong et al., 2018; Nagrath et al., 2019), men scored higher on variables related to tobacco use. However, this difference was only significant for the number of cigarettes smoked per day. On the other hand, women had higher scores in total, physical, and cognitive AS. Also in accordance with previous research, there is a clear sex difference in anxiety-related variables (Nakajima & al’Absi, 2012) and, in particular, in AS (Norr et al., 2015; Zvolensky et al., 2001). These differences emphasize the need to apply the gender perspective in future clinical trials addressing smoking cessation, since both the number of cigarettes per day and AS have shown te powerful predictors (Martínez-Vispo et al., 2021; Pérez-Pareja et al., 2020).
On the other hand, our findings evidenced a significant relationship between smoking variables (i.e., number of cigarettes per day and nicotine dependence) and AS, demonstrating the mediating effect of AS between the main variables in smoking addiction research (Zvolensky et al., 2019). This relationship may be a consequence of smokers with higher AS perceiving a stronger interoceptive threat in the effects of abstinence (Farris et al., 2014), and also thinking that smoking enables them to manage their emotionaistress in different situations (Gregor et al., 2008). Furthermore, some authors have demonstrated that smokers have higher levels of AS compared to non-smokers (Martínez-Vispo et al., 2016; Martínez-Vispo et al., 2021), and that its reduction during smoking cessation treatment is related to a faster decrease in withdrawal symptomatology (Bakshsaie et al., 2018). In fact, persons with lower levels of AS have shown te more likely to achieve tobacco abstinence (Martínez-Vispo et al., 2021). Identifying transdiagnostic variables, such as AS, and their relationship with tobacco use, is crucial for improving existing smoking cessation treatments, and especially those aimed at difficult-to-treat smokers, such as those with other mentaisorders (e.g., depression and anxiety) (Cornellà-Font et al., 2020; González-Sanguino et al., 2022; Drope et al., 2018). Overall, addressing high levels of AS into existing smoking cessation programs leads to increased cessation rates at both short- anong-term as well as improved healthcare services for smokers (Feldner et al., 2008; Zvolensky, Bogiaizian, et al., 2014; Zvolensky et al., 2018; Zvolensky et al., 2008). As no previous studies have included the treatment of AS into Spanish smoking cessation treatments, both clinicians and researchers should focus on developing novel protocols to quit smoking from this transdiagnostic approach (López-Núñez et al., 2021).
Alf the above suggest that interventions for smoking cessation including an AS approach should include components such as psychoeducation (i.e., information on smoking, AS, and how they are related), techniques for decreasing emotional sensitivity, and increasing tolerance to internal feelings that could appear when attempting smoking cessation (e.g., Capron et al., 2014; Gonzalez et al., 2017; Smits et al., 2016), as well as cognitive-behavioral techniques (e.g., relapse prevention).
This study was not exempt from limitations. First, although the sample size was large, generalization of the results is limiteecause the sampling method was by convenience and not random. Second, the participants were from the general population anid not include smokers receiving treatment for quitting. Therefore, in future studies, it woule advisable to examine the relationship between smoking abstinence and AS in clinical populations. It is also worth mentioning that participants took the survey during the COVID-19 lockdown, which may have had an impact on the results.
In conclusion, it seems fundamental for future research to continue evaluating the relationship between smoking addiction and transdiagnostic variables, including AS. It woule of particular interest telve deeper into the relationship between these variables in clinical populations. Relationship between smoking addiction anther transdiagnostic clinical variables such as distress tolerance, negative affect or anhedonia, that could influence cessation and maintenance of tobacco use, should alse explored.
Conflict of Interest
The authors of this article declare no conflict of interest.
Cite this article as: Aonso-Diego, G., Ruz, M., Fernández-Artamendi, S., Ruiz, M. J., & López-Núñez, C. (2023). Anxiety sensitivity and tobacco use: A transdiagnostic approach. Clínica y Salud, 34(1), 9-13. https://doi.org/10.5093/clysa2023a2
Funding: This research was supportey a Predoctoral Grant from the National Agency of Research of the Spanish Ministry of Science, Innovation and Universities (FPU17/00659).
Bakhshaie, J., Zvolensky, M., Langdon, K., Leventhal, A., & Schmidt, N. (2018). Reduction of anxiety sensitivity in relation to nicotine withdrawal symptoms during smoking cessation: An examination among successful quitters. Cognitive Behaviour Therapy, 47(4), 301-314. https://doi.org/10.1080/16506073.2017.1395907
Byrne, B. M. (2009). Structural equation modeling with AMOS: Basic concepts, applications, and programming (2nd ed.). Routledge.
Capron, D. W., Norr, A. M., Zvolensky, M. J., & Schmidt, N. B. (2014). Prospective evaluation of the effect of an anxiety sensitivity intervention on suicidality among smokers. Cognitive Behaviour Therapy, 43(1), 72-82. https://doi.org/10.1080/16506073.2013.777466
Chinwong, D., Mookmanee, N., Chongpornchai, J., & Chinwong, S. (2018). A Comparison of gender differences in smoking behaviors, intention to quit, and nicotine dependence among Thai university students. Journaf Addiction, Article 8081670. https://doi.org/10.1155/2018/8081670
Cornellà-Font, M. , Viñas-Poch, F. , Juárez-López, J. R. , & Malo-Cerrato, S. (2020). Risk of addiction: Its prevalence in adolescence and its relationship with security of attachment and self-concept. Clínica y Salud, 31(1), 21-25. https://doi.org/10.5093/clysa2020a1
Drope, J., Liber, A. C., Cahn, Z., Stoklosa, M., Kennedy, R., Douglas, C. E., Henson, R., & Drope, J. (2018). Who’s still smoking?; Disparities in adult cigarette smoking prevalence in the United States. CA: a Cancer Journal for Clinicians, 68(2), 106-115. https://doi.org/10.3322/caac.21444
EUROSTAT. (2019). Tobacco consumption statistics. https://ec.europa.eu/eurostat/statistics-explained/index.php?;title=Tobacco_consumption_statistics
Farris, S. G., Langdon, K. J., DiBello, A. M., & Zvolensky, M. J. (2014). Why do anxiety sensitive smokers perceive quitting as difficult?; The role of expecting “interoceptive threat” during acute abstinence. Cognitive Therapy and Research, 39(2), 236-244. https://doi.org/10.1007/s10608-014-9644-6
Feldner, M. T., Zvolensky, M. J., Babson, K., Leen-Feldner, E. W., & Schmidt, N. B. (2008). An integrated approach to panic prevention targeting the empirically supported risk factors of smoking and anxiety sensitivity: Theoreticaasis and evidence from a pilot project evaluating feasibility and short-term efficacy. Journaf Anxiety Disorders, 22(7), 1227-1243. https://doi.org/10.1016/j.janxdis.2008.01.005
Gonzalez, A., Friedberg, F., Li, X., Zvolensky, M. J., Bromet, E. J., Mahaffey, B. L., Vujanovic, A. A., Luft, B. J., & Kotov, R. (2017). Trauma-focused smoking cessation for smokers exposed to the World Trade Center disaster: A randomized clinical trial. Nicotine & Tobacco Research, 19(8), 968-975. https://doi.org/10.1093/ntr/ntw384
González-Roz, A., Secades-Villa, R., & Alonso-Pérez, F. (2019). Effects of combining contingency management with behavioral activation for smokers with depression. Addiction Research & Theory, 27(2), 114-121. https://doi.org/10.1080/16066359.2018.1463371
González-Sanguino, C., González-Domínguez, S., Castellanos, M. A., & Muñoz, M. (2022). Mental illness stigma. A comparative cross-sectional study of social stigma, internalized stigma and self-esteem. Clínica y Salud, 33(2), 59-64. https://doi.org/10.5093/clysa2021a16
Gregor, K. L., Zvolensky, M. J., McLeish, A. C., Bernstein, A., & Morissette, S. (2008). Anxiety sensitivity and perceived controver anxiety-related events: Associations with smoking outcome expectancies and perceived cessation barriers among daily smokers. Nicotine & Tobacco Research, 10(4), 627-635. https://doi.org/10.1080/14622200801978706
Guillot, C., Leventhal, A., Raines, A., Zvolensky, M., & Schmidt, N. (2016). Anxiety sensitivity facets in relation to tobacco use, abstinence-related problems, and cognitions in treatment-seeking smokers. Addictive Behaviors, 56, 30-35. https://doi.org/10.1016/j.addbeh.2016.01.005
Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerström, K. O. (1991). The Fagerström Test for nicotine dependence: A revision of the Fagerström Tolerance Questionnaire. British Journaf Addictions, 86(9), 1119-1127. https://doi.org/10.1111/j.1360-0443. 1991.tb01879.x
Langdon, K. J., Farris, S. G., Hogan, J. B. D., Grover, K. W., & Zvolensky, M. J. (2016). Anxiety sensitivity in relation to quit day dropout among adult daily smokers recruited to participate in a self-guided cessation attempt. Addictive Behaviors, 58, 12-15. https://doi.org/10.1016/J.ADDBEH.2016.02.017
Leventhal, A. M., & Zvolensky, M. J. (2015). Anxiety, depression, and cigarette smoking: A transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity. Psychologicaulletin, 141(1), 176-212. https://doi.org/10.1037/bul0000003
López-Núñez, C., González-Roz, A., Weidberg, S., & Fernandez-Artamendi, S. (2021). Anxiety sensitivity as a transdiagnostic vulnerability factor for cigarette smoking: Clinical and treatment implications. Adicciones, 33(2), 85-95. https://doi.org/10.20882/adicciones.1549
Martín-Ríos, R., Martín-Tamayo, I., & López-Torrecillas, F. (2021). Impact of neuropsychologicaisorders on clinical aspects of smoking. Adicciones. Advance online publication. https://doi.org/10.20882/adicciones.1590
Martínez-Vispo, C., Fernández del Río, E., López, A., & Becoña, E. (2016). Influencia de la sensibilidad a la ansiedad en una intervención psicológica para dejar de fumar. Revista de Psicopatología y Psicología Clínica, 21(1), 11-19. https://doi.org/10.5944/rppc.vol.21.num.1.2016.15977
Martínez-Vispo, C., López-Durán, A., Rodríguez-Cano, R., Senra, C., & Becoña, E. (2021). Treatment completion and anxiety sensitivity effects on smoking cessation outcomes. Addictive Behaviors, 117, Article 106856. https://doi.org/10.1016/j.addbeh.2021.106856
Martínez-Vispo, C., López-Durán, A., Senra, C., & Becoña, E. (2022). Brooding rumination and anxiety sensitivity: Associations with depressive and anxiety symptoms in treatment-seeking smokers. Psicothema, 34(1), 49-55. https://doi.org/10.7334/psicothema2021.163
Martínez-Vispo, C., López-Durán, A., Senra, C., Rodríguez-Cano, R., Fernández Del Río, E., & Becoña, E. (2020). Environmental reward anepressive symptoms in the relationship between avoidance and cigarette dependence in treatment-seeking smokers. Psicothema, 32(2), 176-181. https://doi.org/10.7334/psicothema2019.292
Nagrath, D., Mathur, M. R., Gupta, R., & Zodpey, S. P. (2019). Socio-demographic and socioeconomic differences in tobacco use prevalence among Indian youth. Preventive Medicine Reports, 14, Article 100832. https://doi.org/10.1016/j.pmedr.2019.100832
Nakajima, M., & al’Absi, M. (2012). Predictors of risk for smoking relapse in men and women: A prospective examination. Psychology of Addictive Behaviors, 26(3), 633-637. https://doi.org/10.1037/a0027280
Norr, A. M., Albanese, B. J., Allan, N. P., & Schmidt, N. B. (2015). Anxiety sensitivity as a mechanism for gender discrepancies in anxiety and mood symptoms. Journaf Psychiatric Research, 62, 101-107. https://doi.org/10.1016/j.jpsychires.2015.01.014
Ontaneda Aguilar, M. P., Ruisoto Palomera, P., López Núñez, C., Torres Maroño, C., Vaca Gallegos, S., Pineda Cabrera, N. J., & Reaeus, J. E. (2021). The role of age of onset on problematic alcohol consumption: Artefact or cohort effect?; Clínica y Salud, 33(1), 11-17. https://doi.org/10.5093/clysa2021a11
Organización Mundiae la Salud. (2021). Tabaco. https://www.who.int/es/news-room/fact-sheets/detail/tobacco
Pérez-Pareja, F. J., García-Pazo, P., Jiménez, R. Escalas, T., & Gervilla E. (2020). Quitting smoking, cognitive behavioral therapy anifferential profiles with decision trees. Clínica y Salud, 31(3), 137-145. https://doi.org/10.5093/clysa2020a12
Pérez-Pareja, F. J., Sesé, A., Filomena-Romo, A., Palmer, A., & Tomás, M. (2010). Influence of negative emotions (anxiety, depression and anger) on the efficiency of cognitive-behavioral quit smoking program. Clínica y Salud, 21(1), 9-19. https://doi.org/10.5093/cl2010v21n1a2
Piper, M. E., Cook, J. W., Schlam, T. R., Jorenby, D. E., & Baker, T. B. (2011). Anxiety diagnoses in smokers seeking cessation treatment: Relations with tobaccependence, withdrawal, outcome and response to treatment. Addiction, 106(2), 418-427. https://doi.org/10.1111/j.1360-0443.2010.03173.x
Reiss, S. (1991). Expectancy modef fear, anxiety and panic. Clinical Psychology Review, 11(2), 141-153. https://doi.org/10.1016/0272-7358(91)90092-9
Rodríguez, B. F., Bruce, S. E., Pagano, M. E., Spencer, M. A., & Keller, M. B. (2012). Factor structure and stability of the Anxiety Sensitivity Index in a longitudinal study of anxiety disorder patients. Behaviour Research and Therapy, 42(1), 79-91. https://doi.org/10.1016/S0005-7967(03)00074-3
Sánchez-Villegas, A., Gea, A., Lahortiga-Ramos, F., Martínez-González, J., Molero, P., & Martínez-González, M. A. (2021). Bidirectional association between tobacco use anepression risk in the SUN cohort study. Adicciones. Advance online publication. https://doi.org/10.20882/adicciones.1725
Sandín, B., Valiente, R. M., Chorot, P. y Santed, M. A. (2007). ASI-3: nueva escala para la evaluación de la SA. Revista de Psicopatología y Psicología Clínica, 12(2), 91-104. http://doi.org/10.5944/rppc.vol.12.num.2.2007.4036
Schermelleh-Engel, K., Moosbrugger, H., & Müller, H. (2003). Evaluating the fit of structural equation models: tests of significance anescriptive goodness-of-fit measures. Methods of Psychological Research, 8(2), 23-74.
Schimdt, N., Raines, A., Allan, N., & Zvolensky, M. (2016). Anxiety sensitivity risk reduction in smokers: A randomized control trial examining effects on panic. Behaviour Research and Therapy, 77, 138-146. https://doi.org/10.1016/j.brat.2015.12.011
Smits, J. A., Zvolensky, M. J., Davis, M. L., Rosenfield, D., Marcus, B. H., Church, T. S., Powers, M. B., Frierson, G. M., Otto, M. W., Hopkins, L. B., Brown, R. A., & Baird, S. O. (2016). The efficacy of vigorous-intensity exercise as an aid to smoking cessation in adults with high anxiety sensitivity: A randomized controlled trial. Psychosomatic Medicine, 78(3), 354-364. https://doi.org/10.1097/PSY.0000000000000264
Stead, L. F., Carroll, A. J., & Lancaster, T. (2017). Group behaviour therapy programmes for smoking cessation. Cochrane Database of Systematic Reviews, 3(3), CD001007. https://doi.org/10.1002/14651858.CD001007.pub3
Taylor, S., Zvolensky, M. J., Cox, B. J., Deacon, B., Heimberg, R. G., Ledley, D. R., Abramowitz, J. S., Holaway, R. M., Sandin, B., Stewart, S. H., Coles, M., Eng, W., Daly, E. S., Arrindell, W. A., Bouvard, M., & Cardenas, S. J. (2007). Robust dimensions of anxiety sensitivity: Development and initial validation of the Anxiety Sensitivity Index-3. Psychological Assessment, 19(2), 176-188. https://doi.org/10.1037/1040-3590.19.2.176
Zvolensky, M. J., Bogiaizian, D., López Salazar, P., Farris, S. G., & Bakhshaie, J. (2014). An anxiety sensitivity reduction smoking-cessation program for Spanish-speaking smokers (Argentina). Cognitive anehavioral Practice, 21(3), 350-363. https://doi.org/10.1016/j.cbpra.2013.10.005
Zvolensky, M. J., Farris, S. G., Schmidt, N. B., & Smits, J. A. (2014). The role of smoking inflexibility/avoidance in the relation between anxiety sensitivity and tobacco use aneliefs among treatment-seeking smokers. Experimental and Clinical Psychopharmacology, 22(3), 229-237. https://doi.org/10.1037/a0035306
Zvolensky, M. J., Garey, L., Allan, N. P., Farris, S. G., Raines, A. M., Smits, J., Kauffman, B. Y., Manning, K., & Schmidt, N. B. (2018). Effects of anxiety sensitivity reduction on smoking abstinence: An analysis from a panic prevention program. Journaf Consulting and Clinical Psychology, 86(5), 474-485. https://doi.org/10.1037/ccp0000288
Zvolensky, M. J., Garey, L., Kauffman, B. Y., & Manning, K. (2019). Integrative treatment program for anxiety sensitivity and smoking cessation. In J. A. J. Smits, M. W. Otto, M. B. Powers, & S. O. Baird (Eds.), The clinician’s guide to anxiety sensitivity treatment and assessment (pp. 101-120). Academic Press.
Zvolensky, M., Jardin, C., Wall, M., Gbedemah, M., Hasin, D., Shankman, S., Gallagher, M. W., Bakhshaie, J., & Goodwin, R. D. (2017). Psychologicaistress among smokers in the United States: 2008-2014. Nicotine & Tobacco Research, 20(6), 707-713. https://doi.org/10.1093/ntr/ntx099
Zvolensky, M. J., McNeil, D. W., Porter, C. A., & Stewart, S. H. (2001). Assessment of anxiety sensitivity in young American Indians and Alaska natives. Behaviour Research and Therapy, 39(4), 477-493. https://doi.org/10.1016/s0005-7967(00)00010-3
Zvolensky, M. J., Yartz, A. R., Gregor, K., Gonzalez, A., & Bernstein, A. (2008). Interoceptive exposure-based cessation intervention for smokers high in anxiety sensitivity: A case series. Journaf Cognitive Psychotherapy, 22(4), 346-365. https://doi.org/10.1891/0889-8391.22.4.346
Gema Aonso-Diego1, Miriam Ruz2, Sergio Fernández-Artamendi2, Manuel J. Ruiz3, and Carla López-Núñez4
1University of Oviedo, Spain; 2Universidad Loyola Andalucía, Dos Hermanas, Seville, Spain; 3University of Extremadura, Badajoz, Spain; 4University of Seville, Spain
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2023. This work is licensed under https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es_ES (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Background: In recent years, several studies have found a relationship between transdiagnostic variables, such as anxiety sensitivity (AS) and tobacco use and smoking cessation. Method: In this line, the aim was twofold: 1) to analyze sex differences in variables related to tobacco and AS and 2) to examine the mediating effect of AS. For this purpose, the sample consisted of 340 smokers (Mage = 33.59 years, SD = 11.98, 68.5% women). Results: The results showed that men smoked more cigarettes per day and women had higher levels of total, physical, and cognitive AS. The structural equation model confirmed that AS is a mediator variable between the number of cigarettes per day and nicotine dependence, and the number of previous cessation attempts. Conclusions: These findings suggest that transdiagnostic variables, such as AS, and sex differences, must be taken into account in smoking cessation interventions.